Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.2200 (-3.94%) ($1.2200 - $1.2200) on Wed. Dec. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.13% (three month average) | RSI | 25 | Latest Price | $1.2200(-3.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.6% a day on average for past five trading days. | Weekly Trend | ANPC declines -14.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) TIP(15%) VIXM(14%) VXX(12%) GLD(11%) TLT(10%) | Factors Impacting ANPC price | ANPC will decline at least -3.065% in a week (0% probabilities). IFRA(-22%) SDY(-20%) XLP(-18%) VYM(-17%) XLB(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.065% (StdDev 6.13%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-23.94(-2062.3%) | Resistance Level | $1.5 | 5 Day Moving Average | $1.24(-1.61%) | 10 Day Moving Average | $1.3(-6.15%) | 20 Day Moving Average | $1.5(-18.67%) | To recent high | -64.9% | To recent low | 2.5% | Market Cap | $10m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |